Mike Byrom Chief Scientific Officer, BioEden
(PRWEB UK) 11 August 2015
When diabetes mellitus came to claim 39 year old Fernandez Carillo, he was able to have stem cell therapy, without the worry and wait of finding a suitable match, because his own viable cells had been cryogenically preserved by specialist stem cell bank BioEden; stem cells which they had tested, validated, preserved and transported back to the hospital.
Carillo’s decision to bank his own tooth cells, had given him a direct route to stem cell therapy, giving him back hope, dignity, and had bridged the gap to much better health.
Although stem cells have already been used in the treatment of diabetes, this is the first time that stem cells from a tooth have been used, a procedure which removes the stem cells from the tooth after it has been shed naturally or extracted for orthodontic purposes. The successful use of preserved tooth cells in the treatment of diabetes is another world first for BioEden, the pioneers and specialists in tooth cell banking.
After just 12 weeks, the amount of insulin that Carillo was taking was significantly reduced both in quantity and frequency of use. Carillo also reported significant increases in energy levels, a marked decrease in fatigue, rehydrated skin, improved muscle tone and condition in his leg veins and notably the complete disappearance of his blurred vision.
Carillo experienced a complete reversal of many of his symptoms and did not experience any kind of adverse reaction, infection, or other complication
Mike Byrom, Chief Scientific Officer for BioEden said, ‘Based on the measured clinical results and the verbal testimonial from this patient, this treatment was a complete success which has significantly improved the quality of life of this patient. A critical factor in its success was swift access to his own viable cells, cryogenically preserved, a perfect stem cell match’.
To read the full report or to find out more about BioEden visit http://www.bioeden.com